Company / Capital Expenditures
Astrana Health, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$10.1M
FY2025
5-year range
$8.0M / $22.9M
FY2021-FY2025
Trend
+25.8%
vs FY2024
Sector context
#111 of 151
Health Care
What the data says
At $10M, Astrana Health, Inc.'s capital expenditures ranks #111 of 151 in the Health Care sector. Capital Expenditures returned to growth in FY2025 after 2 years of decline, reaching $10M.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of +54.1%.
Declined from $19M to $10M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -23.9%
- 5-Year CAGR
- +54.1%
- 10-Year CAGR
- -
Sector benchmark
#111 of 151 in Health CareTop 74% of 151This company $10.1M Sector average $271.7M
▼
-96.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +54.1%, indicating consistent growth.
- In FY2025, capital expenditures increased 25.8% year-over-year.
- Ranks #111 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.1M | +25.8% |
| FY2024 | $8.0M | -58.2% |
| FY2023 | $19.2M | -16.2% |
| FY2022 | $22.9M | +19.3% |
| FY2021 | $19.2M | +1551.5% |
| FY2020 | $1.2M | +11.7% |
| FY2019 | $1.0M | -10.9% |
| FY2018 | $1.2M | -43.9% |
| FY2017 | $2.1M | -36.9% |
| FY2016 | $3.3M | +1161.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026